FDA Adverse Event Death Summary report: N

ENDEAVOR SPRINT RX

MDR report key: 3112996 · Received May 15, 2013

Report

Report Number
9612164-2013-00537
Event Type
Death
Date Received
May 15, 2013
Date of Event
January 25, 2013
Report Date
May 19, 2014
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

RESULTS: DEATH, PULMONARY EDEMA. CONCLUSIONS: DEATH,PULMONARY EDEMA. (B)(4).

Description of Event or Problem · 1

DURING THE INDEX PROCEDURE THE PATIENT HAD TWO ENDEAVOR SPRINT DRUG ELUTING STENTS IMPLANTED IN THE LCX. APPROXIMATELY 14.5 MONTHS POST INDEX PROCEDURE THE PATIENT EXPIRED. CAUSE OF DEATH WAS HEART FAILURE, ACUTE PULMONARY EDEMA AND RENAL FAILURE. INVESTIGATOR ASSESSED THE EVENT WAS NOT RELATED TO THE STUDY DEVICE.

Description of Event or Problem · 1

ADDITIONAL CAUSE OF DEATH ARE COPD, SHOCK AND RESPIRATORY FAILURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
214427 ENDEAVOR SPRINT RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND 0002379223

Patients

Seq Age Sex Outcome Treatment
1 00063 YR Death CLOPIDOGREL